INTRODUCTION
The diverse biological functions of many proteins depend upon posttranslational modifications (1) . Because the biosynthesis and structure of human hemoglobin are so well understood, this protein is ideally suited for the study of such structural alteration. Fortunately, human hemoglobin is less heterogeneous than that of other mammals. About 90% of hemoglobin of adults and children above the age of 6 mo is Hb A (a2#s). Hb A2 (a285) and Hb F (atys) comprise about 2.5 and 0.5% of the total, respectively. The synthesis of these minor components is controlled by 8-and 7-chain genes. In contrast, the other minor hemoglobin components found in normal adult hemolysate may be posttranslational modifications of Hb A. When human hemolysate is chromatographed on cation exchange resins, three negatively charged minor hemoglobin components are eluted before the main Hb A peak (2, 3) . Hemoglobins Au., Aa, and Al. comprise approximately 1.6, 0.8, and 4% of the total hemoglobin of adult human erythrocytes, respectively. Thus, Hb Al. is the most abundant minor hemoglobin component. Holmquist and Schroeder (4) showed that Hb Al. is structurally identical to Hb A except that an unidentified group was linked to the terminal amino group of the f-chain by means of a Schiff base. Bookchin and Gallop (5) demonstrated that both 8-chains of Hb A1. were attached to a hexose. Recently, we have established the presence of glucose on je-A1. and have presented evidence indicating that this moiety is attached to the N-terminal amino group by a unique ketoamine linkage (6) , formed by a rearrangement of the Schiff base.
Interest in Hb A1. has been considerably enhanced by the fact that this glycoprotein is increased about twofold in patients with diabetes mellitus (7) (8) (9) . Other qualitative and quantitative abnormalities of glycoproteins have been described in both clinical and experimental diabetes (10) and may provide new insights into the pathogenesis of the disease and its complications. An understanding of the biosynthesis of hemoglobin A1. is essential in determining its biological relevance both in normal individuals and in those with diabetes. In this paper, we present both in vitro and in vivo evidence that the formation of hemoglobin Al. is a relatively slow process, probably nonenzymatic in nature, which proThe Journal of Clinical Investigation Volume 57 June 1976-1652-1659ceeds continuously throughout the life-span of the erythrocyte.
METHODS
Specimens of blood and bone marrow were collected in heparin from normal adult volunteers and from selected patients with hemolytic anemias. Hemolysates were prepared by the method of Drabkin (11) In some experiments, dilute hemoglobin solutions were concentrated by pressure filtration before spectrophotometric and radioactivity measurements.
In Titro studies. Suspensions of bone marrow or reticulocyte-rich blood were incubated with tritium and "C-labeled compounds obtained from New England Nuclear, Boston, Mass. 3 ml of autologous plasma containing 45 ,uCi of ['H]-leucine or ["C]glucose and 4.5 mg of unlabeled glucose was mixed with 1 ml of packed cells and incubated at 37°C with gentle shaking. At selected time intervals, aliquots were removed and washed four times with ice-cold saline. Hemolysate was then passed through Sephadex G-100 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) equilibrated with the same developer used in the chromatographic separation of the hemoglobins. In this way, hemoglobin was readily separated from labeled compounds of both lower and higher molecular weight. The labelled hemoglobins were then analyzed on Bio-Rex 70 as described above. In one experiment, globin subunits were prepared from columnpurified hemoglobins (14) . "C and 3H radioactivity was determined on a liquid scintillation counter (Isocap 300, Searle Analytic Inc., Des Plaines, Ill.). To minimize color quenching, hemoglobin solutions were bleached with 10% H202 as described previously (15 In vivo studies. Two individuals were given intravenous infusions of autologous heparinized plasma containing 5 and 20 1LCi of [9Fe]citrate prepared as described above. In the first patient, iron kinetics were measured as part of a general evaluation of erythropoiesis and erythrocyte lifespan. The studies were performed in compliance with the guidelines of the Human Subjects Committee of the Peter Bent Brigham Hospital. Both individuals gave fully informed consent. After the infusion of [9Fe]transferrin, 40-ml blood specimens were withdrawn every 10-20 days. Approximately 4 g of hemoglobin was applied to a preparative Bio-Rex column to obtain sufficient amounts of the minor components for significant measurements of radioactivity. Samples containing 15-250 mg of hemoglobin were each counted for 25 min on the 4th day after collection and also for 100 min after the last day of collection. Radioactivity measurements were corrected for the natural decay of the isotope and for the effect of small changes in sample volume on counting efficiency. The counting error on these samples was estimated to be 5% or less. From the corrected counts per minute of the sample and its volume and hemoglobin concentration, the specific activity was determined.
RESULTS
In vitro studies. Incorporation of [5H]leucine into hemoglobins of reticulocyte-rich blood is shown in Fig.  1 and Table I . Chromatography of the hemolysate on Bio-Rex 70 revealed a front-running radioactive peak which overlapped with Hb Aa -Am. Measurement of absorbances at 540 and 280 nm (not shown) indicated that this labeled peak coincided with the negatively charged nonheme protein (2) . There was no radioactivity peak coincident with the elution of hemoglobin Ale. The counts per minute associated with Hb Ale probably represented a trailing edge from the highly radioactive nonheme protein. Thus the specific activities of Hb Ale calculated from these data and shown in Table I are likely to be artifactually increased. To document this, globin was prepared from this A,0 peak and separated into a-and f-chains. The specific activity of these sub- units was only 19 and 17%, respectively, of the unfractionated hemoglobin. This result indicates that the radioactivity associated with the Hb Ale peak does not reflect incorporation of [3H]leucine into globin subunits. Thus, the true specific activity of Hb Al. was considerably lower than that estimated from the hemoglobin separated on Bio-Rex 70.
One possible explanation for these results is that Hb Ale is synthesized primarily in marrow erythroblasts and that, like Hb As (16) Table I ). An acidic (negatively charged) 'Fe-labeled nonhemoglobin peak was also seen. These data rule out the possibility that Hb Ale is synthesized preferentially in younger erythroid precursors.
Marrow suspensions were also incubated with ["C]-glucose (Fig. 2B) . The amount of radioactivity employed (45 /ACi) was comparable to that in the ['H]leucine incubation ( Fig. 2A) . No significant radioactive peaks were associated with Hb A,.. Similar results were obtained with reticulocyte incubations. The radioactivity associated with the Hb A peak in Fig. 2B probably represents the incorporation of labeled amino acids derived from metabolized glucose.
In vivo studies. Patient L. W. was studied during a period when she was recovering from pure erythrocyte aplasia. Plasma iron turnover was 0.84 mg/kg per day (normal 0.42 mg/kg per day), and erythrocyte incorporation of 'Fe was 42% in 10 days. The half survival time of autologous lCr-labeled erythrocytes was 22 days (normal 25-40 days). As shown in Fig. 3 , 'Fe became rapidly incorporated into Hb A. The specific activity of Hb A remained nearly constant during the 60-day observation period. In contrast, the specific activity of Hb Ate rose in a nearly linear fashion and reached the specific activity of Hb A by day 50. Because the radio- activity of Hb Ala and Aib was low in this study these two minor components were combined. The specific activity of mixtures of Hb Au and Hb Anb paralleled that of Hb A10. These results may be influenced by the fact that this patient had some degree of ineffective erythropoiesis. This study was repeated in a normal subject (Fig. 4) . Because four times as much 'Fe was infused, Hb Ala and Hb Alb contained sufficient radioactivity that their specific activities could be quantitated separately. As expected, the specific activity of Hb A rose to a maximum within 10 days after infusion of 'Fe and fell slowly thereafter because of a small degree of random destruction of erythrocytes.' The specific activities of Hb Ala, Hb Alb, and Hb A10 again rose in nearly linear fashion and reached that of Hb A by day 60. Thereafter, the specific activities of these minor hemoglobins exceeded that of Hb A. No measurements were obtained after day 100 because reutilization of wFe from senescent erythrocytes makes interpretation of such specific activity data unreliable.
As Fig. 5 shows, the content of Hb A10 in erythrocytes of patients with hemolytic anemia and shortened erythrocyte life-span was approximately half the hemoglobin A10 levels in normal individuals. The Hb A,.
peak of two of these patients was analyzed by electro- 1 The fall in specific activity of Hb A cannot be due to slow conversion to Hb A10.
phoresis and found to be contaminated with a substantial amount of Hb F. In contrast, no significant amount of Hb F was detected in the Hb A,. peak from three normal individuals. Hb Ala and Alb were also significantly reduced in these patients. DISCUSSION These experiments demonstrate that the conversion of Hb A to Hb A10 is a slow posttranslational event, occurring continuously throughout the 120-day life-span of normal erythrocytes. This conclusion is supported by the low levels of Hb Ale in patients with hemolysis (17 and Fig. 5 is likely that at least part of Hb Ale radioactivity in these preparations was also due to the presence of acidic nonglobin proteins that co-chromatograph with Hb A1L.
Because of the uncertainties involved in these in vitro studies, it was important to obtain precise data on the biosynthesis of Hb A,. in vivo. After the labeling of a cohort of erythrocytes with 'Fe, a slow and nearly linear increase in the specific activity of Hb A10 was observed. The labeling pattern of the other minor components Hb Ala and Hb Alb was similar to that of Hb A10. The extremely slow conversion of Hb A to Hb A1u suggests a nonenzymatic process. There are only a few examples of nonenzymatic modification of proteins that are known to occur in vivo (1) . These include the formation of most disulfide bonds, the conversion of NH2-glutamine to pyroglutamine and the deamidation of glutamine and asparagine residues.
Hemoglobin A,0 is the product of the chemical condensation of hemoglobin and glucose (6) , reactants that are present in high concentration within the erythrocyte. The reaction is favored by the fact that the N-terminal amino groups of hemoglobin have relatively low pK. (19) , making them very effective nucleophiles at physiological pH. Dixon (20) has shown that the aldehyde of glucose and the amino group of valyhistidine can form a reversible Schiff base linkage when incubated for 30 h at pH 6.2, 50°C in the absence of enzyme or cofactors. Our studies on human Hb A1u (6) 
The data on Fig. 4 give a value for dA1/dt of 7.1 nmol/ml per day. If mean erythrocyte glucose concentration is 4 mM (21) and hemoglobin (afi dimer) is 10 mM, then k = 1.78 X 10' mM-1 day '. It will be of interest to compare this rate constant with that obtained in vitro by incubating ["C] glucose with purified hemoglobin under carefully controlled conditions. The fact that hemoglobins Al and Alb have the same labeling patterns as Ale suggests that they, too, are posttranslational modifications of Hb A. We are currently studying the structure of these two minor components.
As shown in Fig. 4 , the specific activities of hemoglobins Aa, Anb, and A,. reached that of Hb A by day 60, half the life span of the erythrocyte. If hemoglobin A were slowly and irreversibly converted to a minor component A. during the 120-day life-span of erythrocytes, the predicted specific activity pattern after a cohort label would be that shown in Fig. 6 . Our experimental data shown in Fig. 4 follow this theoretical plot with a crossover observed at day 60. The rise in specific activity of Hb A10 that was observed experimentally deviated slightly from linearity and may indicate that the glycosylation of hemoglobin is reversible to a slight degree ( Fig. 6 and Appendix). The failure to observe a continued rise in the specific activity of Hb Al., Alb, and A10 above that of Hb A after day 90 may be due in part to reversible glycosylation and in part to reutilization of 'Fe that accompanies the senescence of the la- ). The experimental data shown in Fig. 4 Care must be taken not to confuse the k2 and k3 calculated from the various initial conditions, as they will in general not be similar.
The experimental data shown in Fig. 4 fit best the condition that the reaction is slightly reversible.
